发明名称
摘要 This invention provides compounds of formula I, <IMAGE> I wherein R is alkyl of 3 to 7 carbon atoms; cycloalkyl of 3 to 7 carbon atoms; cycloalkyl of 3 to 7 carbon atoms monosubstituted with alkyl of 1 to 4 carbon atoms; alpha -dialkylpropinyl of 5 to 9 carbon atoms; alpha -dialkylallyl of 5 to 9 carbon atoms; hydroxyalkyl of 2 to 7 carbon atoms, the hydroxy group thereof being separated by at least two carbon atoms from the nitrogen atom to which R is bound; phenethyl; phenethyl mono- or disubstituted in the phenyl residue independently when di-substituted with halogen of atomic number from 9 to 35, alkyl of 1 to 4 carbon atoms or unbranched alkoxy of 1 to 4 carbon atoms; or adamantyl; and EITHER R1 is phenyl and R2 is hydrogen; OR R1 is alkyl of 1 to 4 carbon atoms or halogen of atomic number from 9 to 35 and R2 is unbranched alkoxy of 1 to 4 carbon atoms or halogen of atomic number from 9 to 35, with the general proviso that the 8-position of the isoquinoline is unsubstituted and any halogen substituent which may be present in the 3- or 4- position is other than fluorine, USEFUL FOR TREATING CORONARY DISEASES, ARRHYTHMIA, HYPERLIPOIDEMIA AND HYPERGLYCEMIA.
申请公布号 NO760951(A) 申请公布日期 1976.09.28
申请号 NO19760000951 申请日期 1976.03.18
申请人 SANDOZ AG 发明人 TROXLER F;WISKOTT E
分类号 C07D217/22;A61K31/473;C07D217/24;C07D263/06 主分类号 C07D217/22
代理机构 代理人
主权项
地址